Metoprolol Succinate Extended-Release Tablets recall: Failed Dissolution
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Why was Metoprolol Succinate Extended-Release Tablets recalled?
Failed Dissolution Specifications
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. .
- Product
- Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
- Recalling firm
- Teva Pharmaceuticals USA, Inc
- Quantity
- 19,056 bottles
- Distribution
- Nationwide
- Recall date
- March 11, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)